BECKY ANDREWS: Open Payments
NPI 1831102201 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 32 payments from 16 companies in 2025. Trend: 2023 $749 · 2024 $826 · 2025 $907
Food & beverage: $851Education: $56
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| Regeneron Healthcare Solutions, Inc. | 5 | $134 |
| ABBVIE INC. | 5 | $112 |
| BioCryst US Sales Co., LLC | 1 | $74 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Inspire Medical Systems, Inc. | 1 | $66 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $53 |
| ALK-Abello, Inc | 2 | $43 |
| Integra LifeSciences Corporation | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
Products named: AIRSUPRA, DUPIXENT, QULIPTA, ORLADEYO, NUCALA, INSPIRE, NEFFY, ACCLARENT AERA.
Industry payments across VA — which companies pay providers there.
